ResMed (RSMD.F) Stock Overview

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details

RSMD.F fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance6/6
Financial Health6/6
Dividends4/6

RSMD.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

ResMed Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for ResMed
Historical stock prices
Current Share PriceUS$30.00
52 Week HighUS$30.00
52 Week LowUS$11.91
Beta0.77
1 Month Change0%
3 Month Change0%
1 Year Changen/a
3 Year Change45.14%
5 Year Change44.23%
Change since IPO997.94%

Recent News & Updates

Recent updates

Shareholder Returns

RSMD.FUS Medical EquipmentUS Market
7D0%-0.4%-0.1%
1Yn/a9.3%13.0%

Return vs Industry: Insufficient data to determine how RSMD.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how RSMD.F performed against the US Market.

Price Volatility

Is RSMD.F's price volatile compared to industry and market?
RSMD.F volatility
RSMD.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.9%
Market Average Movement6.4%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: RSMD.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RSMD.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19899,980Mick Farrellwww.resmed.co.in

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

ResMed Inc. Fundamentals Summary

How do ResMed's earnings and revenue compare to its market cap?
RSMD.F fundamental statistics
Market capUS$37.78b
Earnings (TTM)US$1.31b
Revenue (TTM)US$5.02b
28.8x
P/E Ratio
7.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSMD.F income statement (TTM)
RevenueUS$5.02b
Cost of RevenueUS$2.04b
Gross ProfitUS$2.98b
Other ExpensesUS$1.67b
EarningsUS$1.31b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 31, 2025

Earnings per share (EPS)8.97
Gross Margin59.37%
Net Profit Margin26.15%
Debt/Equity Ratio12.1%

How did RSMD.F perform over the long term?

See historical performance and comparison

Dividends

0.8%
Current Dividend Yield
23%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 05:04
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ResMed Inc. is covered by 59 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterANZ Equities Pty Limited
David RescottBaird
Michael PolarkBaird